iRhythm Technologies, Inc.
IRTCNASDAQHealthcare● Active
$110.58
+$2.48(+2.29%)
Market Cap$3.6B
P/E Ratio—
52W High$212
52W Low$101.75
iRhythm Technologies, Inc. (IRTC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
IRTC · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 30, 2026EPS Actual
-$0.35
Est. -$0.56 · +37.5%
Revenue
$0.20B
Est. $0.19B · +2.7%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 30, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 4-Quarter EPS Beat Streak
IRTC reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 30, 2026 | -$0.01 | — | — | — | $0.22B | — |
| ▲ Q2 FY2026 | Apr 30, 2026 | -$0.56 | -$0.35 | +37.5% | $0.20B | $0.19B | +2.7% |
| ▲ Q1 FY2026 | Feb 19, 2026 | $0.02 | $0.17 | +750.0% | $0.21B | $0.20B | +3.5% |
| ▲ Q4 FY2025 | Oct 30, 2025 | -$0.36 | -$0.06 | +83.3% | $0.19B | $0.20B | -4.4% |
| ▲ Q3 FY2025 | Jul 31, 2025 | -$0.53 | -$0.32 | +39.6% | $0.19B | $0.18B | +6.4% |
| ▼ Q2 FY2025 | May 1, 2025 | -$0.89 | -$0.95 | -6.7% | $0.16B | $0.15B | +3.5% |
| ▲ Q1 FY2025 | Feb 20, 2025 | -$0.29 | $0.01 | +103.5% | $0.16B | $0.16B | +3.8% |
| ▼ Q4 FY2024 | Oct 30, 2024 | -$0.55 | -$1.26 | -129.1% | $0.15B | $0.16B | -6.2% |
Q3 FY2026
Jul 30, 2026
EPS Actual
—
EPS Est.
-$0.01
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 30, 2026Beat
EPS Actual
-$0.35
EPS Est.
-$0.56
EPS Surpr.
+37.5%
Revenue
$0.20B
Q1 FY2026
Feb 19, 2026Beat
EPS Actual
$0.17
EPS Est.
$0.02
EPS Surpr.
+750.0%
Revenue
$0.21B
Q4 FY2025
Oct 30, 2025Beat
EPS Actual
-$0.06
EPS Est.
-$0.36
EPS Surpr.
+83.3%
Revenue
$0.19B
Q3 FY2025
Jul 31, 2025Beat
EPS Actual
-$0.32
EPS Est.
-$0.53
EPS Surpr.
+39.6%
Revenue
$0.19B
Q2 FY2025
May 1, 2025Miss
EPS Actual
-$0.95
EPS Est.
-$0.89
EPS Surpr.
-6.7%
Revenue
$0.16B
Q1 FY2025
Feb 20, 2025Beat
EPS Actual
$0.01
EPS Est.
-$0.29
EPS Surpr.
+103.5%
Revenue
$0.16B
Q4 FY2024
Oct 30, 2024Miss
EPS Actual
-$1.26
EPS Est.
-$0.55
EPS Surpr.
-129.1%
Revenue
$0.15B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.96 | $0.98 | $1.00 | 3 |
| Q3 FY2028 | $0.61 | $0.63 | $0.64 | 3 |
| Q2 FY2028 | $0.41 | $0.42 | $0.43 | 3 |
| Q1 FY2028 | $0.02 | $0.02 | $0.02 | 3 |
| Q4 FY2027 | $0.69 | $0.71 | $0.72 | 2 |
| Q3 FY2027 | $0.29 | $0.30 | $0.31 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.3B | $0.3B | $0.3B | 3 |
| Q3 FY2028 | $0.3B | $0.3B | $0.3B | 5 |
| Q2 FY2028 | $0.3B | $0.3B | $0.3B | 3 |
| Q1 FY2028 | $0.3B | $0.3B | $0.3B | 3 |
| Q4 FY2027 | $0.3B | $0.3B | $0.3B | 4 |
| Q3 FY2027 | $0.3B | $0.3B | $0.3B | 5 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 30, 2026 | +37.5% | $120.75 | $129.16 | +6.96% |
| ▲ Q1 FY2026 | Feb 19, 2026 | +750.0% | $153.85 | $158.88 | +3.27% |
| ▲ Q4 FY2025 | Oct 30, 2025 | +83.3% | $185.29 | $184.12 | -0.63% |
| ▲ Q3 FY2025 | Jul 31, 2025 | +39.6% | $140.08 | $140.18 | +0.07% |
| ▼ Q2 FY2025 | May 1, 2025 | -6.7% | $106.89 | $108.59 | +1.59% |
| ▲ Q1 FY2025 | Feb 20, 2025 | +103.5% | $113.04 | $112.67 | -0.33% |
| ▼ Q4 FY2024 | Oct 30, 2024 | -129.1% | $77.00 | $75.77 | -1.60% |
| ▲ Q3 FY2024 | Aug 1, 2024 | +33.7% | $86.25 | $84.22 | -2.35% |
Q2 FY2026+6.96%
Report Date
Apr 30, 2026
EPS Beat/Miss
+37.5%
Price Before
$120.75
Price After
$129.16
Q1 FY2026+3.27%
Report Date
Feb 19, 2026
EPS Beat/Miss
+750.0%
Price Before
$153.85
Price After
$158.88
Q4 FY2025-0.63%
Report Date
Oct 30, 2025
EPS Beat/Miss
+83.3%
Price Before
$185.29
Price After
$184.12
Q3 FY2025+0.07%
Report Date
Jul 31, 2025
EPS Beat/Miss
+39.6%
Price Before
$140.08
Price After
$140.18
Q2 FY2025+1.59%
Report Date
May 1, 2025
EPS Beat/Miss
-6.7%
Price Before
$106.89
Price After
$108.59
Q1 FY2025-0.33%
Report Date
Feb 20, 2025
EPS Beat/Miss
+103.5%
Price Before
$113.04
Price After
$112.67
Q4 FY2024-1.60%
Report Date
Oct 30, 2024
EPS Beat/Miss
-129.1%
Price Before
$77.00
Price After
$75.77
Q3 FY2024-2.35%
Report Date
Aug 1, 2024
EPS Beat/Miss
+33.7%
Price Before
$86.25
Price After
$84.22
Avg Beat Reaction+1.17%
Avg Miss Reaction-0.01%
Beat Rate6 / 8 quarters
Largest Move+6.96% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: IRTC ends December
iRhythm Technologies, Inc. (IRTC) most recently reported earnings on April 30, 2026 for Q2 FY2026, posting EPS of $-0.35 — beating the analyst consensus of $-0.56 by +37.5%. IRTC has beaten EPS estimates for 4 consecutive quarters. The next IRTC earnings date is expected around September 1, 2026.
Each quarter, investors track IRTC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. IRTC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
IRTC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
IRTC earnings · 5 questionsiRhythm Technologies, Inc.'s next earnings report is expected around September 1, 2026. IRTC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; IRTC historically reports after market close (AMC).
IRTC earnings datewhen is IRTC earningsIRTC next earnings datewhen does IRTC report earningsIRTC earnings calendar
▸ Source: FMP · iRhythm Technologies, Inc. SEC filings · US GAAP · iRhythm Technologies, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026